Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost, thanks to a new grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to researchers led by UCSF bioengineer Shuvo Roy, PhD, and Vanderbilt University nephrologist William Fissell, MD.
Artificial Kidney Research Advances Through UCSF Collaboration
The UCSF-Stanford Pediatric Device Consortium is funded by the U.S. Food & Drug Administration's Office of Orphan Products Development under grant no. P50FD007967.
